Autologous Fat Grafting in Radiated Soft Tissue Reconstruction

Sponsor
University of Chicago (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05890196
Collaborator
(none)
10
1
34
0.3

Study Details

Study Description

Brief Summary

The purpose of this study is to observe the effect of autologous fat grafting on soft tissue reconstruction of the breast following radiation treatment. Moving fat from one part of the body to another has been used for reconstruction for hundreds of years. However, it is not fully understood how well this works in reconstruction after radiation is used for cancer treatment.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is a single-arm, prospective pilot study that will objectively assess outcomes in patients electively undergoing AFT for breast or chest wall reconstruction. Patients planning to undergo autologous fat transfer for breast or chest wall reconstruction will be enrolled prospectively. As this is a pilot study, the study team plans to enroll ten (10) patients to demonstrate the feasibility of the protocol and pathway as well as establish preliminary data for extramural funding. The research will include capturing 2-dimensional (2-D) and 3-dimensional (3-D) photographs as well as ultrasound (US) soft tissue assessments to determine volume retention and changes in the reconstructed area. Participants will undergo this imaging of their breast and chest wall and complete two questionnaires to evaluate patient satisfaction, quality of life, and late effects of radiation following fat grafting over a 12-month period, all standard of care. The 3D photographs and US are routinely used in practice but will be performed for research purposes in this study.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    10 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    A Pilot Study Treating Radiation Injury With Autologous Fat Transfer
    Actual Study Start Date :
    Mar 1, 2023
    Anticipated Primary Completion Date :
    Dec 31, 2024
    Anticipated Study Completion Date :
    Dec 31, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Change in Skin Fibrometry before and after fat transfer in reconstruction. [12 months]

      Soft tissue assessment is made using a non-invasive device SkinFibrometer (Delfin Kuopio, Finland) that measures tissue edema and skin elasticity. Measurements will be taken in all four quadrants of the affected (radiated) breast or reconstructed breast before and after the grafting procedure.

    Secondary Outcome Measures

    1. Change in Radiation Injury before and after fat transfer. [12 months]

      Radiation injury assessment is made using the validated tool Late Effects Normal Tissue Task Force - Subjective Objective Management and Analytic (LENT-SOMA) score. Assessment will be made before and after the fat transfer procedure. Overall, scores are based on 12 categories, scored 0-4 with a higher score indicating more significant radiation injury.

    2. Change in patient reported satisfaction of the breast measure before and after fat transfer. [12 months]

      The BREAST Q validated patient survey measures several realms related to breast reconstruction and allows an assessment of satisfaction and physical well-being before and after reconstruction. The survery responses are tallied and converted to a score of 100 with a higher score being more satisfied or better outcome. In addition, a change in score of 8 or more points is a clinically meaningful difference according to normative studies.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Able to give consent

    • Undergoing elective autologous fat grafting

    • Previously treated for breast cancer

    • Previous treatment included radiation therapy to the breast/chest wall.

    Exclusion Criteria:
    • Unable to give consent

    • No history of radiation to the breast or chest wall

    • No prior treatment for breast cancer

    • No indication for autologous fat grafting

    • Currently pregnant or breastfeeding

    • Currently consuming nicotine products (smoking, vaping, patches, gum)

    • Under the age of 18

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Summer E Hanson Chicago Illinois United States 60637

    Sponsors and Collaborators

    • University of Chicago

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Chicago
    ClinicalTrials.gov Identifier:
    NCT05890196
    Other Study ID Numbers:
    • IRB21-1183
    First Posted:
    Jun 6, 2023
    Last Update Posted:
    Jun 6, 2023
    Last Verified:
    May 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 6, 2023